Alterations of hepatic microsomal drug metabolism by glucagon

J. V. Aranda, K. W. Renton

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

2 Citas (Scopus)

Resumen

The effect of glucagon on the components of the hepatic microsomal electron transport chain (NADPH oxidase, NADPH cytochrome c reductase (EC 1.6.2.4), cytochrome P 450, and NADPH cytochrome P 450 reductase), and on two representative oxidative pathways (aminopyrine N demethylation, a type I substrate oxidation; and aniline p hydroxylation, a type II substrate oxidation) was determined. Microsomes from rats pretreated with glucagon (300 μg/kg per day for 3 days) showed a significant decrease in NADPH oxidase and aminopyrine N demethylation with a prolonged hexobarbital sleeping time, and a significant increase in aniline p hydroxylation. Microsomes from rats pretreated with a lower dose of glucagon (30 μg/kg per day for 3 days) showed a significant decrease in the microsomal N demethylation of aminopyrine. Glucagon had no effect when added in vitro to microsomes, suggesting that the in vivo effects of glucagon are mediated indirectly in the intact animal.

Idioma originalEnglish
Páginas (desde-hasta)873-879
Número de páginas7
PublicaciónCanadian Journal of Physiology and Pharmacology
Volumen53
N.º5
DOI
EstadoPublished - 1975
Publicado de forma externa

ASJC Scopus Subject Areas

  • Physiology
  • Pharmacology
  • Physiology (medical)

PubMed: MeSH publication types

  • Journal Article

Huella

Profundice en los temas de investigación de 'Alterations of hepatic microsomal drug metabolism by glucagon'. En conjunto forman una huella única.

Citar esto